id: Q9Y625
gene_symbol: GPC6
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: GPC6 encodes Glypican-6, a GPI-anchored heparan sulfate proteoglycan (HSPG) that functions as a cell surface
  co-receptor for Hedgehog (Hh) and Wnt signaling pathways. GPC6 is tethered to the outer leaflet of the plasma membrane via
  a C-terminal GPI anchor and bears heparan sulfate (HS) glycosaminoglycan chains near its C-terminus. In Hedgehog signaling,
  GPC6 binds Hh ligand via its core protein domain and interacts with PTCH1 via its HS chains, promoting Hh-PTCH1 engagement
  at the primary cilium. Upon Hh stimulation, GPC6 translocates into the cilium. GPC6 also binds Wnt5a with high affinity
  (KD ~1.4 nM) and activates non-canonical Wnt signaling through ROR2-DVL pathways, promoting JNK and p38 MAPK activation.
  The protein plays essential roles in skeletal development and endochondral ossification, and biallelic loss-of-function
  mutations cause autosomal recessive omodysplasia type 1 (OMOD1), characterized by rhizomelic limb shortening and craniofacial
  abnormalities. GPC6 also regulates intestinal elongation by coordinating Hh and non-canonical Wnt signaling. In cancer cells,
  NFAT-induced GPC6 expression promotes invasive migration through Wnt5A signaling.
existing_annotations:
- term:
    id: GO:0016477
    label: cell migration
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation based on phylogenetic inference from glypican family orthologs. Supported by direct experimental
      evidence showing GPC6 promotes breast cancer cell invasive migration through Wnt5A signaling (PMID:21871017). Gpc6-null
      mice also show reduced mesenchymal proliferation during intestinal development.
    action: ACCEPT
    reason: Cell migration is a well-documented function of GPC6. PMID:21871017 demonstrates that GPC6 promotes invasive migration
      in breast cancer cells, and silencing GPC6 with shRNA potently blocks this phenotype. The IBA annotation is consistent
      with experimental evidence.
    supported_by:
    - reference_id: PMID:21871017
      supporting_text: "Expression of GPC6 in response to NFAT signalling promotes invasive migration, whereas GPC6 silencing with shRNA (small-hairpin RNA) potently blocks this phenotype."
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation suggesting GPC6 localizes to extracellular matrix based on phylogenetic inference. However, GPC6
      is primarily a GPI-anchored cell surface proteoglycan. While HSPGs can interact with ECM components, the primary localization
      is the plasma membrane cell surface.
    action: MODIFY
    reason: GPC6 is a GPI-anchored protein localized to the cell surface/plasma membrane, not the extracellular matrix proper.
      UniProt describes it as "Cell membrane; Lipid-anchor, GPI-anchor; Extracellular side." A more accurate annotation would
      be cell surface (GO:0009986) which is already present as an IBA annotation.
    proposed_replacement_terms:
    - id: GO:0009986
      label: cell surface
    supported_by:
    - reference_id: UniProt:Q9Y625
      supporting_text: "SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI- anchor {ECO:0000250}; Extracellular side {ECO:0000250}."
- term:
    id: GO:0098696
    label: regulation of neurotransmitter receptor localization to postsynaptic specialization membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation from phylogenetic inference. While glypicans are expressed in neural tissues and some family members
      (particularly GPC4) have documented synaptic roles, specific evidence for GPC6 in neurotransmitter receptor localization
      is limited. GPC6 expression in the brain is relatively low compared to other tissues.
    action: KEEP_AS_NON_CORE
    reason: The IBA inference may reflect a conserved glypican family function, but GPC6-specific evidence for synaptic receptor
      localization is lacking. The core functions of GPC6 are in Hedgehog and Wnt signaling for skeletal and intestinal development.
      UniProt notes that GPC6 is "not detected in peripheral blood leukocytes" and is most abundant in ovary, liver, kidney,
      small intestine and colon.
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0009986
    label: cell surface
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation consistent with GPC6 being a GPI-anchored cell surface proteoglycan. Strongly supported by biochemical
      evidence and the known GPI-anchor attachment site at Ser529.
    action: ACCEPT
    reason: GPC6 is a GPI-anchored protein localized to the cell surface. This is a core localization annotation consistent
      with all experimental evidence. UniProt confirms "Cell membrane; Lipid-anchor, GPI-anchor; Extracellular side." Deep
      research confirms GPC6 resides at the plasma membrane and can be recruited to the primary cilium.
    supported_by:
    - reference_id: UniProt:Q9Y625
      supporting_text: "SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI- anchor {ECO:0000250}; Extracellular side {ECO:0000250}."
    - reference_id: file:human/GPC6/GPC6-deep-research-falcon.md
      supporting_text: "GPC6 resides at the plasma membrane and, in Hedgehog (Hh) signaling contexts, can be recruited to the primary cilium where Hh signaling is initiated"
- term:
    id: GO:0045202
    label: synapse
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: IBA annotation from phylogenetic inference. Some glypican family members have documented synaptic roles, but
      GPC6-specific synaptic localization evidence is limited. GPC6 is most highly expressed in non-neural tissues.
    action: KEEP_AS_NON_CORE
    reason: While the IBA inference may be valid based on family conservation, GPC6-specific synaptic localization is not
      strongly supported. GPC6 core functions are in Hedgehog/Wnt signaling for skeletal and intestinal development. The synapse
      localization may be a minor or tissue-specific function.
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: IEA annotation based on UniProt subcellular location annotation. GPC6 can be processed by furin-like convertases
      and shed, creating soluble secreted forms that retain regulatory activity.
    action: ACCEPT
    reason: GPC6 can be released as a secreted form (secreted glypican-6) after proteolytic processing. UniProt describes
      a "Secreted glypican-6" chain. The annotation is appropriate for the soluble form.
    supported_by:
    - reference_id: UniProt:Q9Y625
    - reference_id: doi:10.1016/j.isci.2023.108095
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: IEA annotation consistent with GPC6 being a GPI-anchored plasma membrane protein. The glypican domain (IPR001863)
      predicts plasma membrane localization.
    action: ACCEPT
    reason: GPC6 is anchored to the plasma membrane via GPI anchor at Ser529. This is a core localization annotation consistent
      with all experimental evidence and the protein's function as a cell surface co-receptor.
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0009966
    label: regulation of signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: IEA annotation from InterPro glypican domain. GPC6 regulates both Hedgehog and Wnt signal transduction pathways
      as a co-receptor.
    action: MODIFY
    reason: While regulation of signal transduction is accurate, more specific terms are available. GPC6 specifically activates
      non-canonical Wnt signaling and positively regulates Hedgehog/Smoothened signaling. Consider more specific annotations
      for these pathways.
    proposed_replacement_terms:
    - id: GO:2000052
      label: positive regulation of non-canonical Wnt signaling pathway
    - id: GO:0045880
      label: positive regulation of smoothened signaling pathway
    supported_by:
    - reference_id: PMID:21871017
      supporting_text: "The mechanism by which GPC6 promotes invasive migration involves inhibition of canonical beta-catenin and Wnt signalling, and up-regulation of non-canonical Wnt5A signalling leading to the activation of JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein kinase)."
    - reference_id: doi:10.1083/jcb.201605119
- term:
    id: GO:0031012
    label: extracellular matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: IEA annotation from InterPro glypican domain. However, GPC6 is primarily a GPI-anchored cell surface protein,
      not an ECM component.
    action: MODIFY
    reason: GPC6 is a GPI-anchored cell surface protein. While HSPGs can interact with ECM, GPC6 is membrane-anchored. The
      cell surface annotation (GO:0009986) is more accurate.
    proposed_replacement_terms:
    - id: GO:0009986
      label: cell surface
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: IEA annotation from ARBA machine learning. HSPGs are known to be degraded in lysosomes, which explains this annotation
      in the context of proteoglycan turnover.
    action: KEEP_AS_NON_CORE
    reason: Lysosomal localization reflects degradation of the proteoglycan, not its functional site. This is part of normal
      protein turnover rather than a site where GPC6 performs its co-receptor function.
    supported_by:
    - reference_id: Reactome:R-HSA-1667005
- term:
    id: GO:0098552
    label: side of membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: IEA annotation based on GPI-anchor keyword. GPC6 is on the extracellular side of the plasma membrane via its
      GPI anchor.
    action: MODIFY
    reason: This is too general. A more specific term would be GO:0031232 (extrinsic component of external side of plasma
      membrane) or the already-annotated cell surface (GO:0009986).
    proposed_replacement_terms:
    - id: GO:0009986
      label: cell surface
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0045202
    label: synapse
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: IEA annotation from Ensembl Compara ortholog transfer. Similar to the IBA annotation, synaptic localization is
      inferred from orthologs but not strongly supported by GPC6-specific evidence.
    action: KEEP_AS_NON_CORE
    reason: Duplicate of IBA annotation. Synaptic localization may be valid but is not a core function of GPC6 based on current
      evidence. Core functions are in skeletal and intestinal development.
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9940993
  review:
    summary: TAS annotation from Reactome pathway for PXYLP1 dephosphorylation of xylose moiety during GAG linker biosynthesis.
      Golgi is where HS-GAG biosynthesis occurs.
    action: KEEP_AS_NON_CORE
    reason: GPC6 transits through the Golgi during biosynthesis where its HS chains are added. This is a biosynthetic intermediate
      localization, not the functional site. The core functional localization is the cell surface/plasma membrane.
    supported_by:
    - reference_id: Reactome:R-HSA-2022928
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9941039
  review:
    summary: TAS annotation from Reactome pathway for FAM20B phosphorylation of xylose moiety during GAG linker biosynthesis.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization. Duplicate of previous Golgi annotation in different Reactome pathway context.
    supported_by:
    - reference_id: Reactome:R-HSA-1971475
- term:
    id: GO:0015026
    label: coreceptor activity
  evidence_type: NAS
  original_reference_id: PMID:24431302
  review:
    summary: NAS annotation citing a review on Wnt signaling in dopaminergic neuron development. GPC6 functions as a co-receptor
      for Hedgehog and Wnt ligands, facilitating their engagement with primary receptors.
    action: ACCEPT
    reason: Coreceptor activity is a core molecular function of GPC6. The protein binds Hh ligand and promotes Hh-PTCH1 engagement.
      It also binds Wnt5a with high affinity to facilitate non-canonical Wnt signaling. UniProt describes it as a "Putative
      cell surface coreceptor for growth factors."
    supported_by:
    - reference_id: UniProt:Q9Y625
    - reference_id: doi:10.1083/jcb.201605119
    - reference_id: doi:10.1016/j.matbio.2019.11.002
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:29162697
  review:
    summary: IPI annotation from a study on EB1-binding myomegalin complex. The study identified interactome partners but
      appears to be a high-throughput screen that may include non-specific interactions.
    action: MARK_AS_OVER_ANNOTATED
    reason: '"Protein binding" is uninformative and does not specify the functional significance of the interaction. More
      specific binding activities (Wnt-protein binding GO:0017147, or smoothened binding if applicable) would be preferable.
      The cited paper focuses on SMYLE/myomegalin and microtubule dynamics, not GPC6 specifically.'
    proposed_replacement_terms:
    - id: GO:0017147
      label: Wnt-protein binding
    supported_by:
    - reference_id: doi:10.1016/j.matbio.2019.11.002
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: HDA
  original_reference_id: PMID:21630459
  review:
    summary: HDA annotation from a proteomic characterization of human sperm nucleus. This high-throughput mass spectrometry
      study identified GPC6 among 403 proteins in isolated sperm nuclei.
    action: MARK_AS_OVER_ANNOTATED
    reason: GPC6 is a GPI-anchored cell surface protein with no known nuclear function. Detection in a sperm nuclear proteome
      is likely due to contamination or artifactual association during sample preparation. This contradicts the well-established
      cell surface localization and function of GPC6.
    supported_by:
    - reference_id: UniProt:Q9Y625
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1878002
  review:
    summary: TAS annotation from Reactome pathway for xylosyltransferases adding xylose to core protein during GAG linker
      biosynthesis.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain synthesis in the Golgi.
    supported_by:
    - reference_id: Reactome:R-HSA-1878002
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1889955
  review:
    summary: TAS annotation from Reactome pathway for B3GAT dimer transferring GlcA to tetrasaccharide linker.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain synthesis.
    supported_by:
    - reference_id: Reactome:R-HSA-1889955
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1889978
  review:
    summary: TAS annotation from Reactome pathway for B3GALT6 transferring Gal to tetrasaccharide linker.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain synthesis.
    supported_by:
    - reference_id: Reactome:R-HSA-1889978
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2022851
  review:
    summary: TAS annotation from Reactome pathway for EXT1:EXT2 transferring GlcNAc to heparan chain.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain elongation.
    supported_by:
    - reference_id: Reactome:R-HSA-2022851
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2022856
  review:
    summary: TAS annotation from Reactome pathway for EXT1:EXT2 transferring GlcA to heparan.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain elongation.
    supported_by:
    - reference_id: Reactome:R-HSA-2022856
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2022860
  review:
    summary: TAS annotation from Reactome pathway for NDST1-4 sulfating glucosamine residue to form HS.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2022860
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2022887
  review:
    summary: TAS annotation from Reactome pathway for NDST1-4 N-deacetylating GlcNAc residues in heparan.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2022887
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2024108
  review:
    summary: TAS annotation from Reactome pathway for HSPG secretion to plasma membrane.
    action: KEEP_AS_NON_CORE
    reason: Transit through Golgi during secretory pathway before reaching plasma membrane.
    supported_by:
    - reference_id: Reactome:R-HSA-2024108
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2076383
  review:
    summary: TAS annotation from Reactome pathway for HS3ST1 sulfating GlcN at C3 in HS.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2076383
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2076392
  review:
    summary: TAS annotation from Reactome pathway for EXT1:EXT2 GlcA transfer to heparan.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain elongation.
    supported_by:
    - reference_id: Reactome:R-HSA-2076392
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2076419
  review:
    summary: TAS annotation from Reactome pathway for HS6STs sulfating GlcN at C6.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2076419
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2076508
  review:
    summary: TAS annotation from Reactome pathway for HS2ST1 trimer sulfating IdoA at C2.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2076508
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2076611
  review:
    summary: TAS annotation from Reactome pathway for HS3ST2-6 sulfating GlcN at C3.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain modification.
    supported_by:
    - reference_id: Reactome:R-HSA-2076611
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3560802
  review:
    summary: TAS annotation from Reactome pathway for defective B3GAT3 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3560802
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656254
  review:
    summary: TAS annotation from Reactome pathway for defective EXT2 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3656254
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656257
  review:
    summary: TAS annotation from Reactome pathway for defective EXT1 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3656257
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656261
  review:
    summary: TAS annotation from Reactome pathway for defective EXT1 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3656261
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3656267
  review:
    summary: TAS annotation from Reactome pathway for defective EXT2 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3656267
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1678694
  review:
    summary: TAS annotation from Reactome pathway for Heparanase 2 (HPSE2) binding to HSPGs at plasma membrane.
    action: ACCEPT
    reason: Plasma membrane is the core functional localization of GPC6 as a GPI-anchored proteoglycan.
    supported_by:
    - reference_id: Reactome:R-HSA-1678694
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2024084
  review:
    summary: TAS annotation from Reactome pathway for HS-GAG translocation to lysosome for degradation.
    action: ACCEPT
    reason: Plasma membrane is the functional site before internalization for degradation.
    supported_by:
    - reference_id: Reactome:R-HSA-2024084
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2024108
  review:
    summary: TAS annotation from Reactome pathway for HSPG secretion to plasma membrane.
    action: ACCEPT
    reason: This accurately describes the delivery of GPC6 to its functional site.
    supported_by:
    - reference_id: Reactome:R-HSA-2024108
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2404131
  review:
    summary: TAS annotation from Reactome pathway for LRP-mediated transport of retinoid esters with HSPG and apoE.
    action: ACCEPT
    reason: Plasma membrane localization where GPC6 participates in retinoid transport pathway.
    supported_by:
    - reference_id: Reactome:R-HSA-2404131
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2423785
  review:
    summary: TAS annotation from Reactome pathway for retinoid esters binding apoE and HSPG.
    action: ACCEPT
    reason: Plasma membrane localization for retinoid transport function.
    supported_by:
    - reference_id: Reactome:R-HSA-2423785
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2429643
  review:
    summary: TAS annotation from Reactome pathway for NREH hydrolysis of retinoid esters.
    action: ACCEPT
    reason: Plasma membrane localization in retinoid metabolism context.
    supported_by:
    - reference_id: Reactome:R-HSA-2429643
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9694579
  review:
    summary: TAS annotation from Reactome pathway for SARS-CoV-2 Spike binding ACE2. HSPGs can serve as attachment factors
      for viral entry.
    action: ACCEPT
    reason: Plasma membrane localization where HSPGs may facilitate viral attachment.
    supported_by:
    - reference_id: Reactome:R-HSA-9694579
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9694661
  review:
    summary: TAS annotation from Reactome pathway for TMPRSS2-mediated SARS-CoV-2 entry.
    action: ACCEPT
    reason: Plasma membrane localization in viral entry context.
    supported_by:
    - reference_id: Reactome:R-HSA-9694661
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9698988
  review:
    summary: TAS annotation from Reactome pathway for SARS-CoV-2 membrane fusion.
    action: ACCEPT
    reason: Plasma membrane localization in viral entry context.
    supported_by:
    - reference_id: Reactome:R-HSA-9698988
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9699007
  review:
    summary: TAS annotation from Reactome pathway for FURIN-mediated SARS-CoV-2 entry.
    action: ACCEPT
    reason: Plasma membrane localization in viral entry context.
    supported_by:
    - reference_id: Reactome:R-HSA-9699007
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9836899
  review:
    summary: TAS annotation from Reactome pathway for RSV sG binding to HSPGs.
    action: ACCEPT
    reason: Plasma membrane localization where HSPGs serve as viral attachment factors.
    supported_by:
    - reference_id: Reactome:R-HSA-9836899
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1667005
  review:
    summary: TAS annotation from Reactome pathway for heparanase cleaving HS in lysosome.
    action: KEEP_AS_NON_CORE
    reason: Lysosomal localization reflects degradation of the proteoglycan, not its functional site.
    supported_by:
    - reference_id: Reactome:R-HSA-1667005
- term:
    id: GO:0043202
    label: lysosomal lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2024084
  review:
    summary: TAS annotation from Reactome pathway for HS-GAG translocation to lysosome for degradation.
    action: KEEP_AS_NON_CORE
    reason: Lysosomal localization reflects degradation pathway, not functional site.
    supported_by:
    - reference_id: Reactome:R-HSA-2024084
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1889981
  review:
    summary: TAS annotation from Reactome pathway for B4GALT7 transferring Gal to xylosyl-unit.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during GAG linker synthesis.
    supported_by:
    - reference_id: Reactome:R-HSA-1889981
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3560804
  review:
    summary: TAS annotation from Reactome pathway for defective B4GALT7 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-3560804
- term:
    id: GO:0016477
    label: cell migration
  evidence_type: IDA
  original_reference_id: PMID:21871017
  review:
    summary: IDA annotation based on direct experimental evidence showing GPC6 promotes breast cancer cell invasive migration
      through Wnt5A signaling. Silencing GPC6 with shRNA potently blocks cell migration.
    action: ACCEPT
    reason: Strong experimental evidence demonstrating GPC6's role in promoting cell migration. The study used shRNA knockdown
      and overexpression to show GPC6 is necessary and sufficient for NFAT-induced invasive migration in breast cancer cells.
    supported_by:
    - reference_id: PMID:21871017
      supporting_text: "Expression of GPC6 in response to NFAT signalling promotes invasive migration, whereas GPC6 silencing with shRNA (small-hairpin RNA) potently blocks this phenotype."
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9036285
  review:
    summary: TAS annotation from Reactome pathway for defective EXT1 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-9036285
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9036289
  review:
    summary: TAS annotation from Reactome pathway for defective EXT2 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-9036289
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9953259
  review:
    summary: TAS annotation from Reactome pathway for EXTL3 dimer transferring GlcNAc to GAG linker.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic intermediate localization during HS chain initiation.
    supported_by:
    - reference_id: Reactome:R-HSA-9953259
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-1667005
  review:
    summary: TAS annotation from Reactome pathway for heparanase cleaving HS in lysosome.
    action: KEEP_AS_NON_CORE
    reason: The Golgi annotation in context of this reaction seems incorrect - HPSE acts in lysosome.
    supported_by:
    - reference_id: Reactome:R-HSA-1667005
- term:
    id: GO:0005796
    label: Golgi lumen
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4420365
  review:
    summary: TAS annotation from Reactome pathway for defective B3GALT6 disease mechanism.
    action: KEEP_AS_NON_CORE
    reason: Biosynthetic pathway annotation in context of disease mechanism.
    supported_by:
    - reference_id: Reactome:R-HSA-4420365
core_functions:
- molecular_function:
    id: GO:0015026
    label: coreceptor activity
  description: GPC6 functions as a cell surface co-receptor for Hedgehog (Hh) and Wnt signaling pathways. It binds Hh ligand
    via its core protein domain and interacts with PTCH1 via its heparan sulfate chains, promoting Hh-PTCH1 engagement at
    the primary cilium. GPC6 also binds Wnt5a with high affinity (KD ~1.4 nM) to facilitate non-canonical Wnt signaling.
  supported_by:
  - reference_id: file:human/GPC6/GPC6-deep-research-falcon.md
    supporting_text: "Purified GPC6 binds Wnt5a with high affinity by surface plasmon resonance (SPR): ka approximately 4.65x10^5 M-1s-1 and kd approximately 6.82x10-4 s-1 (KD approximately 1.4 nM)"
  - reference_id: PMID:21871017
    supporting_text: "GPC6 is a novel NFAT target gene in breast cancer cells that promotes invasive migration through Wnt5A signalling."
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10480909
  title: Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans.
  findings:
  - statement: Initial characterization of GPC6 as a cell surface HSPG with tissue-specific expression
    supporting_text: "The glypican-6 mRNA encodes a protein of 555 amino acids that is most homologous to glypican-4 (identity of 63%). Expression of this protein in Namalwa cells shows a core protein of approximately 60 kDa that is substituted with heparan sulfate only."
- id: PMID:19481194
  title: Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive
    omodysplasia.
  findings:
  - statement: Biallelic loss-of-function GPC6 mutations cause autosomal recessive omodysplasia type 1
    supporting_text: "We now report that autosomal-recessive omodysplasia, a genetic condition characterized by short-limbed short stature, craniofacial dysmorphism, and variable developmental delay, maps to chromosome 13 (13q31.1-q32.2) and is caused by point mutations or by larger genomic rearrangements in glypican 6 (GPC6)."
  - statement: Mutations lead to impaired endochondral ossification and skeletal abnormalities
    supporting_text: "GPC6 seems to have a previously unsuspected role in endochondral ossification and skeletal growth, and its functional abrogation results in a short-limb phenotype."
- id: PMID:21630459
  title: Proteomic characterization of the human sperm nucleus.
  findings: []
- id: PMID:21871017
  title: NFAT promotes carcinoma invasive migration through glypican-6.
  findings:
  - statement: NFAT transcriptionally induces GPC6 expression in breast cancer cells
    supporting_text: "NFAT transcriptionally regulates GPC6 induction in breast cancer cells and binds to three regulatory elements in the GPC6 proximal promoter."
  - statement: GPC6 promotes invasive migration through non-canonical Wnt5A signaling
    supporting_text: "Expression of GPC6 in response to NFAT signalling promotes invasive migration, whereas GPC6 silencing with shRNA (small-hairpin RNA) potently blocks this phenotype."
  - statement: GPC6 inhibits canonical Wnt/beta-catenin signaling
    supporting_text: "The mechanism by which GPC6 promotes invasive migration involves inhibition of canonical Î²-catenin and Wnt signalling, and up-regulation of non-canonical Wnt5A signalling leading to the activation of JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein kinase)"
  - statement: GPC6 activates JNK and p38 MAPK signaling
    supporting_text: "up-regulation of non-canonical Wnt5A signalling leading to the activation of JNK (c-Jun N-terminal kinase) and p38 MAPK (mitogen-activated protein kinase)."
- id: PMID:24431302
  title: Wnt signaling in midbrain dopaminergic neuron development and regenerative medicine for Parkinson's disease.
  findings: []
- id: PMID:29162697
  title: EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.
  findings: []
- id: UniProt:Q9Y625
  title: UniProt entry for Glypican-6 (GPC6_HUMAN)
  findings:
  - statement: GPC6 is a GPI-anchored cell surface proteoglycan
    supporting_text: "Cell surface proteoglycan that bears heparan sulfate."
  - statement: Functions as putative co-receptor for growth factors
    supporting_text: "Putative cell surface coreceptor for growth factors, extracellular matrix proteins, proteases and anti-proteases"
- id: Reactome:R-HSA-1667005
  findings: []
  title: Reactome pathway R-HSA-1667005
- id: Reactome:R-HSA-1678694
  findings: []
  title: Reactome pathway R-HSA-1678694
- id: Reactome:R-HSA-1878002
  findings: []
  title: Reactome pathway R-HSA-1878002
- id: Reactome:R-HSA-1889955
  findings: []
  title: Reactome pathway R-HSA-1889955
- id: Reactome:R-HSA-1889978
  findings: []
  title: Reactome pathway R-HSA-1889978
- id: Reactome:R-HSA-1889981
  findings: []
  title: Reactome pathway R-HSA-1889981
- id: Reactome:R-HSA-2022851
  findings: []
  title: Reactome pathway R-HSA-2022851
- id: Reactome:R-HSA-2022856
  findings: []
  title: Reactome pathway R-HSA-2022856
- id: Reactome:R-HSA-2022860
  findings: []
  title: Reactome pathway R-HSA-2022860
- id: Reactome:R-HSA-2022887
  findings: []
  title: Reactome pathway R-HSA-2022887
- id: Reactome:R-HSA-2024084
  findings: []
  title: Reactome pathway R-HSA-2024084
- id: Reactome:R-HSA-2024108
  findings: []
  title: Reactome pathway R-HSA-2024108
- id: Reactome:R-HSA-2076383
  findings: []
  title: Reactome pathway R-HSA-2076383
- id: Reactome:R-HSA-2076392
  findings: []
  title: Reactome pathway R-HSA-2076392
- id: Reactome:R-HSA-2076419
  findings: []
  title: Reactome pathway R-HSA-2076419
- id: Reactome:R-HSA-2076508
  findings: []
  title: Reactome pathway R-HSA-2076508
- id: Reactome:R-HSA-2076611
  findings: []
  title: Reactome pathway R-HSA-2076611
- id: Reactome:R-HSA-2404131
  findings: []
  title: Reactome pathway R-HSA-2404131
- id: Reactome:R-HSA-2423785
  findings: []
  title: Reactome pathway R-HSA-2423785
- id: Reactome:R-HSA-2429643
  findings: []
  title: Reactome pathway R-HSA-2429643
- id: Reactome:R-HSA-3560802
  findings: []
  title: Reactome pathway R-HSA-3560802
- id: Reactome:R-HSA-3560804
  findings: []
  title: Reactome pathway R-HSA-3560804
- id: Reactome:R-HSA-3656254
  findings: []
  title: Reactome pathway R-HSA-3656254
- id: Reactome:R-HSA-3656257
  findings: []
  title: Reactome pathway R-HSA-3656257
- id: Reactome:R-HSA-3656261
  findings: []
  title: Reactome pathway R-HSA-3656261
- id: Reactome:R-HSA-3656267
  findings: []
  title: Reactome pathway R-HSA-3656267
- id: Reactome:R-HSA-4420365
  findings: []
  title: Reactome pathway R-HSA-4420365
- id: Reactome:R-HSA-9036285
  findings: []
  title: Reactome pathway R-HSA-9036285
- id: Reactome:R-HSA-9036289
  findings: []
  title: Reactome pathway R-HSA-9036289
- id: Reactome:R-HSA-9694579
  findings: []
  title: Reactome pathway R-HSA-9694579
- id: Reactome:R-HSA-9694661
  findings: []
  title: Reactome pathway R-HSA-9694661
- id: Reactome:R-HSA-9698988
  findings: []
  title: Reactome pathway R-HSA-9698988
- id: Reactome:R-HSA-9699007
  findings: []
  title: Reactome pathway R-HSA-9699007
- id: Reactome:R-HSA-9836899
  findings: []
  title: Reactome pathway R-HSA-9836899
- id: Reactome:R-HSA-9940993
  findings: []
  title: Reactome pathway R-HSA-9940993
- id: Reactome:R-HSA-9941039
  findings: []
  title: Reactome pathway R-HSA-9941039
- id: Reactome:R-HSA-9953259
  findings: []
  title: Reactome pathway R-HSA-9953259
proposed_new_terms: []
suggested_questions:
- question: What is the precise mechanism by which GPC6 heparan sulfate chains contribute to Hedgehog-PTCH1 interaction specificity?
- question: Does GPC6 have roles in other signaling pathways beyond Hedgehog and Wnt (e.g., BMP, FGF)?
- question: What is the functional significance of GPC6-GPC4 interaction (reported in IntAct)?
suggested_experiments:
- description: Structure-function analysis of GPC6 HS chain sulfation patterns and their contribution to Wnt5a versus Hh binding
    specificity
- description: CRISPR knockout studies in human cell models to confirm GPC6 requirement for Hedgehog pathway activation
- description: Proximity labeling (BioID or APEX) to identify the full GPC6 interactome at the primary cilium during Hh signaling
